EXAGEN INC. (Nasdaq:XGN)

Health Care/Life Sciences • Medical Equipment/Supplies

CIK 1274737

Company

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Address
1261 Liberty Way
Suite C
Vista, California 92081

Employees
204

Stock Info

Close
$1.9500

Day Range
1.8800 - 2.0100

52 Week Range
1.3300 - 3.9232

Average volume
55.36K

Short Interest
6.73K (02/15/24)

% of Float Shorted
0.09%

Market Cap
$32.39M

Revenue
$45.56M

Net Income
-$47.39M

2020 Sales Growth
N/A

Rev. per Employee
$253.04K

P/E Ratio
N/A

EPS
-$1.8634

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Executive Chairman
Tina Susan Nova PhD

President, Chief Executive Officer & Director
John Aballi MBA

Director
Paul H Kim MBA, CPA

Independent Director
Ebetuel Pallares PhD, MBA

Independent Director
Bruce C Robertson MBA, PhD

Independent Director
Brian P Birk MBA

Independent Director
Wendy S Johnson MBA

Independent Director
Franklin Michael Stokes MBA

Independent Director
Ana Hooker MBA

SEC filings

Date	Form	Event
12 Dec, 2024	SC 13G/A
27 Nov, 2024	4
19 Nov, 2024	4
18 Nov, 2024	4
12 Nov, 2024	10-Q
12 Nov, 2024	8-K
8 Oct, 2024	144
4 Sep, 2024	4
4 Sep, 2024	3
9 Aug, 2024	144
5 Aug, 2024	8-K
5 Aug, 2024	10-Q
2 Aug, 2024	8-K/A
2 Aug, 2024	8-K
14 Jun, 2024	3
14 Jun, 2024	4
12 Jun, 2024	4
12 Jun, 2024	4
12 Jun, 2024	4
12 Jun, 2024	4
11 Jun, 2024	8-K
16 May, 2024	4
13 May, 2024	S-8
13 May, 2024	8-K
13 May, 2024	10-Q
26 Apr, 2024	DEF 14A
26 Apr, 2024	8-K
26 Apr, 2024	DEFA14A
26 Apr, 2024	ARS
18 Mar, 2024	10-K
18 Mar, 2024	8-K
6 Mar, 2024	4
4 Mar, 2024	4
22 Feb, 2024	4
22 Feb, 2024	4
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
9 Feb, 2024	SC 13G/A
8 Feb, 2024	4
2 Feb, 2024	SC 13G/A
22 Jan, 2024	SC 13G/A
8 Jan, 2024	8-K
11 Dec, 2023	8-K
29 Nov, 2023	EFFECT
29 Nov, 2023	424B5
28 Nov, 2023	CORRESP
27 Nov, 2023	S-3/A
22 Nov, 2023	UPLOAD
20 Nov, 2023	424B5
17 Nov, 2023	S-3
17 Nov, 2023	8-K
13 Nov, 2023	10-Q
13 Nov, 2023	8-K
26 Oct, 2023	8-K
18 Oct, 2023	4
6 Sep, 2023	4
7 Aug, 2023	10-Q
7 Aug, 2023	8-K
26 Jul, 2023	4
26 Jul, 2023	3
24 Jul, 2023	8-K
14 Jun, 2023	8-K
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
13 Jun, 2023	4
24 May, 2023	DEFA14A
18 May, 2023	S-8
15 May, 2023	8-K
15 May, 2023	10-Q
4 May, 2023	8-K
28 Apr, 2023	DEF 14A
28 Apr, 2023	ARS
28 Apr, 2023	DEFA14A
23 Mar, 2023	8-K
20 Mar, 2023	8-K
20 Mar, 2023	10-K
3 Mar, 2023	4
3 Mar, 2023	4
1 Mar, 2023	4
1 Mar, 2023	4
14 Feb, 2023	SC 13G/A
13 Feb, 2023	SC 13G/A
13 Feb, 2023	SC 13G/A
10 Feb, 2023	4
10 Feb, 2023	4
9 Feb, 2023	SC 13G/A
7 Feb, 2023	SC 13G/A
6 Feb, 2023	SC 13G/A
2 Feb, 2023	SC 13G/A
23 Jan, 2023	SC 13G/A
23 Jan, 2023	8-K
9 Jan, 2023	8-K
9 Dec, 2022	4
5 Dec, 2022	8-K
23 Nov, 2022	SC 13G
21 Nov, 2022	10-Q/A
21 Nov, 2022	10-Q
14 Nov, 2022	8-K
14 Nov, 2022	NT 10-Q
20 Oct, 2022	8-K	CEO Change
18 Oct, 2022	4
18 Oct, 2022	3
15 Sep, 2022	424B5
15 Sep, 2022	8-K
4 Aug, 2022	10-Q
4 Aug, 2022	8-K
21 Jun, 2022	4
21 Jun, 2022	8-K
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
11 May, 2022	S-8
11 May, 2022	8-K
11 May, 2022	10-Q
28 Apr, 2022	DEFA14A
28 Apr, 2022	8-K
28 Apr, 2022	DEF 14A
22 Mar, 2022	10-K
22 Mar, 2022	8-K
2 Mar, 2022	4
2 Mar, 2022	4
2 Mar, 2022	4
2 Mar, 2022	4
15 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
10 Feb, 2022	SC 13G/A
8 Feb, 2022	4
8 Feb, 2022	4
8 Feb, 2022	SC 13G/A
8 Feb, 2022	4
8 Feb, 2022	4
20 Jan, 2022	SC 13G/A
19 Jan, 2022	SC 13G/A
10 Jan, 2022	8-K
27 Dec, 2021	SC 13G
17 Dec, 2021	SC 13G
10 Nov, 2021	8-K
10 Nov, 2021	10-Q
25 Oct, 2021	8-K
19 Oct, 2021	8-K
7 Sep, 2021	4
27 Aug, 2021	8-K
9 Aug, 2021	8-K
9 Aug, 2021	10-Q
6 Aug, 2021	4
4 Aug, 2021	4
30 Jul, 2021	8-K
30 Jul, 2021	4
30 Jul, 2021	3
29 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	8-K
21 Jun, 2021	3
21 Jun, 2021	4
17 May, 2021	4
11 May, 2021	8-K
11 May, 2021	S-8
11 May, 2021	10-Q
27 Apr, 2021	DEF 14A
27 Apr, 2021	DEFA14A
9 Apr, 2021	SC 13G/A
1 Apr, 2021	10-K/A
25 Mar, 2021	3
23 Mar, 2021	424B5
23 Mar, 2021	8-K
22 Mar, 2021	8-K
22 Mar, 2021	424B5
16 Mar, 2021	10-K
16 Mar, 2021	8-K
25 Feb, 2021	4
25 Feb, 2021	4
25 Feb, 2021	4
24 Feb, 2021	SC 13D
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
11 Feb, 2021	SC 13G
11 Feb, 2021	SC 13G/A
8 Feb, 2021	4
26 Jan, 2021	4
21 Jan, 2021	4
20 Jan, 2021	4
15 Jan, 2021	4
14 Jan, 2021	4
11 Jan, 2021	8-K
11 Jan, 2021	4

Last update:2024-03-06 12:42:31.850380

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.